Gilead’s remdesivir gets US FDA approval for use in hospitalized COVID-19 patients

10/23/2020 1:21:00 AM

The U.S. FDA approved Gilead Sciences Inc’s antiviral drug remdesivir for treating patients hospitalized with COVID-19, making it the first and only drug approved for the disease.

The U.S. FDA approved Gilead Sciences Inc’s antiviral drug remdesivir for treating patients hospitalized with COVID-19, making it the first and only drug approved for the disease.

The U.S. Food and Drug Administration on Thursday approved Gilead Sciences Inc's antiviral drug remdesivir for treating patients hospitalized with COVID-19, making it the first and only drug

/ 04:43 AM October 23, 2020An ampule of Gilead Sciences COVID-19 antiviral remdesivir is pictured during a news conference at the University Hospital Eppendorf (UKE) in Hamburg, Germany, April 8, 2020, as the spread of coronavirus disease (COVID-19) continues. Ulrich Perrey/Pool via REUTERS

The U.S. Food and Drug Administration on Thursday approved Gilead Sciences Inc’s antiviral drug remdesivir for treating patients hospitalized with COVID-19, making it the first and only drug approved for the disease.Gilead said it is currently meeting real-time demand for remdesivir, which is sold under the brand name Veklury, in the United States and anticipates meeting global demand by the end of October.

Read more: Inquirer »

Less vaccine wastage if those with comorbidities got 2nd booster earlier – expert

'There was some element of delay on the part of the DOH to implement the second booster for those with comorbidities,' says infectious diseases specialist Dr. Rontgene Solante Read more >>

US is nearing 'rapid acceleration' of COVID-19 cases, expert warns, as daily infections top 60,000A leading health expert says US COVID-19 cases will begin to rapidly accelerate in a week as the country topped 60,000 new infections Tuesday — triple what the daily average was back in June, when restrictions had begun to ease.

Golf: No spectators for US Women's Open in Covid-19 safety move

First large-scale US COVID-19 vaccine trial reaches target enrollment of 30,000 participantsModerna, the first company to start US clinical trials of a COVID-19 vaccine, finished enrolling all 30,000 of its participants.

Next up in hunt for Covid-19 vaccine: Testing shots in kidsTHE global hunt for a Covid-19 vaccine for kids is only just beginning — a lagging start that has some US pediatricians worried they may not know if...

Virgin coconut oil shows potential in treating COVID-19 – expert- expert Dear abias cbn plz read..abias cbn talaga nman ohh.. Iba talaga kapag VIRGIN coconut oil, kahit covid napapagaling 🤣🤣🤣

NAIA limits passenger arrivals to 2,500 daily amid delays in COVID-19 testsSo frustrating, testing facities are available but due to late payment of govt OFW now hostage again. Time is so important to OFW. Take care of yourself and your loved ones, the disinfectant bracelet is always with you! Just two days!!! Our hand sanitizer bracelets for just 9.99!!! And that's not all, choose 3 pay only for 2!!!

Reuters / 04:43 AM October 23, 2020 An ampule of Gilead Sciences COVID-19 antiviral remdesivir is pictured during a news conference at the University Hospital Eppendorf (UKE) in Hamburg, Germany, April 8, 2020, as the spread of coronavirus disease (COVID-19) continues.COVID fatigue " and said more restrictions could be on the way if residents don't help bring COVID-19 numbers down.NEW YORK -- Spectators will not be allowed for the 75th US Women's Open in December at Houston, Texas, due to Covid-19 safety concerns, the US Golf Association announced Wednesday.endIndex: (CNN) -- Moderna, the first company to start US clinical trials of a COVID-19 vaccine, on Thursday finished enrolling all 30,000 of its participants.

Ulrich Perrey/Pool via REUTERS The U.S. And as holidays approach , experts worry gatherings will only help drive an already rampant spread. Food and Drug Administration on Thursday approved Gilead Sciences Inc’s antiviral drug remdesivir for treating patients hospitalized with COVID-19, making it the first and only drug approved for the disease. "While we're disappointed that we won't be able to welcome fans and their unmatched energy at Champions Golf Club, we know this is the right decision for the community and players. Gilead said it is currently meeting real-time demand for remdesivir, which is sold under the brand name Veklury, in the United States and anticipates meeting global demand by the end of October. "If you really want to get together indoors, everybody should quarantine themselves for 14 days, and then get tested which would substantially reduce the risk," emergency physician Dr. ADVERTISEMENT Remdesivir, previously granted emergency use authorization by the FDA for COVID-19, was one of the drugs used to treat U." Half of the participants received the vaccine and half received a placebo, or a shot of saline that does nothing.

S. CDC guidelines for safer holidays States take additional measures Illinois Gov. Reduced daylight forced organizers to use both the Jackrabbit and Cypress Creek courses to stage all four rounds of the LPGA major event, which will be staged without traditional qualifying. President Donald Trump’s coronavirus infection. Remdesivir has become the standard of care for patients hospitalized with severe COVID-19 after a major study led by the National Institutes of Health showed that it reduced hospital stays by five days.B. FEATURED STORIES NEWSINFO .